ROR2 mRNA expression was reported to be downregulated in primary colorectal tumours compared to normal colon epithelium in a small patient cohort and functional and in vivo studies pointed to a tumour suppressor role [23,24,25]. This evidence concerns the gene ROR2 and colorectal neoplasm.